Albert Einstein Healthcare Network — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Albert Einstein Healthcare Network appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

15 shown

Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeletonNCT06225830 · lead sponsor · 2024-06-04

Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast SurgeryNCT04554316 · lead sponsor · 2020-11-01

Health Literacy Activation RCT Among the COPD Patients and Designated Support DyadNCT03721315 · lead sponsor · 2019-06-15

Initiative to Minimize Disparities in Postoperative Prostate Cancer CareNCT03755492 · lead sponsor · 2019-04-01

Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital DischargeNCT04277780 · lead sponsor · 2018-10-31

Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory FailureNCT03353064 · lead sponsor · 2017-10-18

Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.NCT02963597 · lead sponsor · 2016-10-01

Study of Respiratory Depression When Using a Hydromorphone Pain ProtocolNCT01784991 · lead sponsor · 2011-12-01

Effect of Treating Sleep Disorder Breathing in Patients With Resistant HypertensionNCT00973531 · lead sponsor · 2009-05-01

Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant HypertensionNCT00953797 · lead sponsor · 2009-05-01

Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure PatientsNCT00804349 · lead sponsor · 2008-10-01

Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous InfusionNCT00806910 · lead sponsor · 2008-10-01

Short Term Hemodynamic Effects of Controlled Slow Breathing With Biofeedback in Patients With Heart FailureNCT00971386 · lead sponsor · 2008-02-01

Study of Left Ventricular Dyssynchrony in Heart Failure PatientsNCT00953953 · lead sponsor · 2007-01-01

Octreotide for the Treatment of Sulfonylurea-Associated HypoglycemiaNCT00804297 · lead sponsor · 2005-06-01

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Albert Einstein Healthcare Network as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

conivaptan1

hydromorphone1

conivaptan RxCUI 302285 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial hydromorphone RxCUI 3423 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor15

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.